← Back to Patent Explorer
US3983121A Expired / Lapsed US ⏱️ 0.0 years remaining

1-Substituted 4-(β-2-quinolylethyl)piperazines and 1,2,3,4-tetrahydroquinolyl-ethyl analogues thereof

Assignee: Council of Scientific and Industrial Research
•
Filing: 1974-07-01
•
Granted: 1976-09-28
•
Expires: 1994-07-01
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Pharmacologically active 1-substituted 4-(β-2-quinolylethyl)piperazines of the formula ##SPC1## And their 1,2,3,4-tetrahydroquinolylethyl analogues, wherein R represents a lower alkyl, a phenyl, benzyl or a phenethyl group; and pharmaceutically acceptable acid addition and quaternary ammonium salts thereof.

Inventors

  • 👤 Varanasi Aruna Murthi
  • 👤 Padam Chand Jain
  • 👤 Jitendra Nath Sharma
  • 👤 Rikhab Chand Srimal
  • 👤 Bhola Nath Dhawan
  • 👤 Nitya Anand

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-08 15:13
CPC Classifications
C; C07; C07D; C07D401/00; C07D401/02; C07D401/06

Claims Analysis

Total Claims: 29
Claim 1
Independent Claim 41 words
A compound which is a member of the group consisting of: 1-(m-tolyl)-4-(β-2-quinolylethyl)piperazine, 1-(m-tolyl)-4-(β-2-quinolylethyl)piperazine hydrochloride, 1-(m-tolyl)-4-[β-2-(1,2,3,4-tetrahydroquinolyl)ethyl]piperazine, 1-(m-tolyl)-4-[β-2-(1,2,3,4-tetrahydroquinolyl)-ethyl]piperazine hydrochloride, 1-(o-tolyl)-4-(β-2-quinolylethyl)piperazine, 1-(p-tolyl)-4-(β-2-quinolylethyl)piperazine, 1-phenyl-4-(β-2-quinolylethyl)piperazine, 1-(p-methoxyphenyl)-4-(β-2-quinolylethyl)piperazine, 1-(o-methoxyphenyl)-4-(β-2-quinolylethyl)piperazine, 1-(2,5-xylyl)-4-(β-2-quinolylethyl)piperazine, 1-(p-chlorophenyl)-4-(β-2-quinolylethyl)piperazine, 1-methyl-4-(β-2-quinolylethyl)piperazine, 1-(o-chlorophenyl)-4-(β-2-quinolylethyl)piperazine, 1-(m-chlorophenyl)-4-(β-2-quinolylethyl)piperazine, 1-(m-trifluoromethylphenyl)-4-(β-2-quinolylethyl)piperazine, 1-(3,4-dichlorophenyl)-4-(β-2-quinolylethyl)piperazine, 1-(2,4-xylyl)-4-(β-2-quinolylethyl)piperazine, 1-(3,4-xylyl)-4-(β-2-quinolylethyl)piperazine, 1-(β-phenethyl)-4-(β-2-quinolylethyl)piperazine, 1-(o-fluorophenyl)-4-(β-2-quinolylethyl)piperazine, 1-(m-fluorophenyl)-4-(β-2-quinolylethyl)piperazine, 1-(p-fluorophenyl)-4-(β-2-quinolylethyl)piperazine, 1-benzyl-4-(β-2-quinolylethyl)piperazine, 1-(m-tolyl)-4-[β-2-(1,2,3,4-tetrahydroquinolylethyl)]piperazine, 1-(o-tolyl)-4-[β-2-(1,2,3,4-tetrahydroquinolylethyl)]piperazine, 1-(p-tolyl)-4-[β-2-(1,2,3,4-tetrahydroquinolylethyl)]piperazine and 1-(p-methoxyphenyl)-4-[β-2-(1,2,3,4-tetrahydroquinolylethyl)]piperazine.
Claim 2
Dependent Claim 41 words
A compound which is a member of the group consisting of: 1-(m-tolyl)-4-(β-2-quinolylethyl)piperazine, 1-(m-tolyl)-4-(β-2-quinolylethyl)piperazine hydrochloride, 1-(m-tolyl)-4-[β-2-(1,2,3,4-tetrahydroquinolyl)ethyl]piperazine, 1-(m-tolyl)-4-[β-2-(1,2,3,4-tetrahydroquinolyl)-ethyl]piperazine hydrochloride, 1-(o-tolyl)-4-(β-2-quinolylethyl)piperazine, 1-(p-tolyl)-4-(β-2-quinolylethyl)piperazine, 1-phenyl-4-(β-2-quinolylethyl)piperazine, 1-(p-methoxyphenyl)-4-(β-2-quinolylethyl)piperazine, 1-(o-methoxyphenyl)-4-(β-2-quinolylethyl)piperazine, 1-(2,5-xylyl)-4-(β-2-quinolylethyl)piperazine, 1-(p-chlorophenyl)-4-(β-2-quinolylethyl)piperazine, 1-methyl-4-(β-2-quinolylethyl)piperazine, 1-(o-chlorophenyl)-4-(β-2-quinolylethyl)piperazine, 1-(m-chlorophenyl)-4-(β-2-quinolylethyl)piperazine, 1-(m-trifluoromethylphenyl)-4-(β-2-quinolylethyl)piperazine, 1-(3,4-dichlorophenyl)-4-(β-2-quinolylethyl)piperazine, 1-(2,4-xylyl)-4-(β-2-quinolylethyl)piperazine, 1-(3,4-xylyl)-4-(β-2-quinolylethyl)piperazine, 1-(β-phenethyl)-4-(β-2-quinolylethyl)piperazine, 1-(o-fluorophenyl)-4-(β-2-quinolylethyl)piperazine, 1-(m-fluorophenyl)-4-(β-2-quinolylethyl)piperazine, 1-(p-fluorophenyl)-4-(β-2-quinolylethyl)piperazine, 1-benzyl-4-(β-2-quinolylethyl)piperazine, 1-(m-tolyl)-4-[β-2-(1,2,3,4-tetrahydroquinolylethyl)]piperazine, 1-(o-tolyl)-4-[β-2-(1,2,3,4-tetrahydroquinolylethyl)]piperazine, 1-(p-tolyl)-4-[β-2-(1,2,3,4-tetrahydroquinolylethyl)]piperazine and 1-(p-methoxyphenyl)-4-[β-2-(1,2,3,4-tetrahydroquinolylethyl)]piperazine.
Claim 3
Dependent Claim 10 words
The compound of claim 1 wherein the compound is 1-(m-tolyl)-4-(β-2-quinolylethyl)piperazine.
Claim 4
Dependent Claim 11 words
The compound of claim 1 wherein the compound is 1-(m-tolyl)-4-(β-2-quinolylethyl)piperazine hydrochloride.
Claim 5
Dependent Claim 10 words
The compound of claim 1 wherein the compound is 1-(m-tolyl)-4-[β-2-(1,2,3,4-tetrahydroquinolyl)ethyl]piperazine.
Claim 6
Dependent Claim 11 words
The compound of claim 1 wherein the compound is 1-(m-tolyl)-4-[β-2-(1,2,3,4-tetrahydroquinolyl)ethyl]piperazine hydrochloride.
Claim 7
Dependent Claim 10 words
The compound of claim 1 wherein the compound is 1-(o-tolyl)-4-(β-2-quinolylethyl)piperazine.
Claim 8
Dependent Claim 10 words
The compound of claim 1 wherein the compound is 1-(p-tolyl-4-(β-2-quinolylethyl)piperazine.
Claim 9
Dependent Claim 10 words
The compound of claim 1 wherein the compound is 1-phenyl-4-(β-2-quinolylethyl)piperazine.
Claim 10
Dependent Claim 10 words
The compound of claim 1 wherein the compound is 1-(p-methoxyphenyl)-4-(β-2-quinolylethyl)piperazine.
Claim 11
Dependent Claim 10 words
The compound of claim 1 wherein the compound is 1-(o-methoxyphenyl)-4-(β-2-quinolylethyl)piperazine.
Claim 12
Dependent Claim 10 words
The compound of claim 1 wherein the compound is 1-(2,5-xylyl)-4-(β-2-quinolylethyl)piperazine.
Claim 13
Dependent Claim 10 words
The compound of claim 1 wherein the compound is 1-(p-chlorophenyl)-4-(β-2-quinolylethyl)piperazine.
Claim 14
Dependent Claim 10 words
The compound of claim 1 wherein the compound is 1-methyl-4-(β-2-quinolylethyl)piperazine.
Claim 15
Dependent Claim 10 words
The compound of claim 1 wherein the compound is 1-(o-chlorophenyl)-4-(β-2-quinolylethyl)piperazine.
Claim 16
Dependent Claim 10 words
The compound of claim 1 wherein the compound is 1-(m-chlorophenyl)-4-(β-2-quinolylethyl)piperazine.
Claim 17
Dependent Claim 10 words
The compound of claim 1 wherein the compound is 1-(m-trifluoromethylphenyl)-4-(β-2-quinolylethyl)piperazine.
Claim 18
Dependent Claim 10 words
The compound of claim 1 wherein the compound is 1-(3,4-dichlorophenyl)-4-(β-2-quinolylethyl)piperazine.
Claim 19
Dependent Claim 10 words
The compound of claim 1 wherein the compound is 1-(2,4-xylyl)-4-(β-2-quinolylethyl)piperazine.
Claim 20
Dependent Claim 10 words
The compound of claim 1 wherein the compound is 1-(3,4-xylyl)-4-(β-2-quinolylethyl)piperazine.
Claim 21
Dependent Claim 10 words
The compound of claim 1 wherein the compound is 1-(β-phenethyl)-4-(β-2-quinolylethyl)piperazine.
Claim 22
Dependent Claim 10 words
The compound of claim 1 wherein the compound is 1-(o-fluorophenyl)-4-(β-2-quinolylethyl)piperazine.
Claim 23
Dependent Claim 10 words
The compound of claim 1 wherein the compound is 1-(m-fluorophenyl)-4-(β-2-quinolylethyl)piperazine.
Claim 24
Dependent Claim 10 words
The compound of claim 1 wherein the compound is 1-(p-fluorophenyl)-4-(β-2-quinolylethyl)piperazine.
Claim 25
Dependent Claim 10 words
The compound of claim 1 wherein the compound is 1-benzyl-4-(β-2-quinolylethyl)piperazine.
Claim 26
Dependent Claim 10 words
The compound of claim 1 wherein the compound is 1-(m-tolyl)-4-[β-2-(1,2,3,4-tetrahydroquinolylethyl)]piperazine.
Claim 27
Dependent Claim 11 words
The compound of claim 1 wherein the compound is 1-(o-tolyl)-4-[β-2-(1,2,3,4-tetrahydroquinolylethyl)] piperazine.
Claim 28
Dependent Claim 10 words
The compound of claim 1 wherein the compound is 1-(p-tolyl)-4-[β-2-(1,2,3,4-tetrahydroquinolylethyl)]piperazine.
Claim 29
Dependent Claim 10 words
The compound of claim 1 wherein the compound is 1-(p-methoxyphenyl)-4-[β-2-(1,2,3,4-tetrahydroquinolylethyl)]piperazine.

References Cited (Backward Citations)

US3362956A Cited
US3821228A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1979-09-28 1980-03-29 1980-09-28 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1983-09-28 1984-03-29 1984-09-28 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1987-09-28 1988-03-29 1988-09-28 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag